Asia Pacific

New York, New York, U.S., September 10, 2026 Breakthrough T1D has announced the publication of new international consensus guidance...

Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...

Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...

Zug, Switzerland | July 20, 2026 Galderma announced the expansion of its Alastin® regenerative skincare brand across the Japan...